Jefferies Financial Group Inc. Sells 51,390 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Key Points

• Jefferies Financial Group Inc. has significantly reduced its position in Henry Schein, selling 51,390 shares to hold 31,710 shares, a 61.8% decrease in its stake during the 1st quarter.
• Other hedge funds, including Farther Finance Advisors LLC and State of Alaska Department of Revenue, have increased their stakes in Henry Schein, highlighting shifting investment strategies among institutional investors.
• Henry Schein's stock was up 0.5% and reported earnings of $1.15 per share, exceeding expectations, though revenue of $3.17 billion fell short of the $3.24 billion estimate.

Jefferies Financial Group Inc. decreased its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 61.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 31,710 shares of the company's stock after selling 51,390 shares during the quarter. Jefferies Financial Group Inc.'s holdings in Henry Schein were worth $2,172,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Farther Finance Advisors LLC grew its holdings in Henry Schein by 237.3% during the 1st quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock worth $186,000 after acquiring an additional 1,898 shares during the period. State of Alaska Department of Revenue grew its holdings in Henry Schein by 2.8% during the 1st quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock worth $1,000,000 after acquiring an additional 395 shares during the period. Oppenheimer Asset Management Inc. grew its holdings in Henry Schein by 5.2% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock worth $941,000 after acquiring an additional 678 shares during the period. GAMMA Investing LLC grew its holdings in Henry Schein by 37.8% during the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock worth $270,000 after acquiring an additional 1,081 shares during the period. Finally, Wellington Management Group LLP grew its holdings in Henry Schein by 12.6% during the 4th quarter. Wellington Management Group LLP now owns 6,902 shares of the company's stock worth $478,000 after acquiring an additional 775 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Stock Down 7.4%

HSIC traded down $5.19 during midday trading on Tuesday, reaching $64.83. The company's stock had a trading volume of 4,502,243 shares, compared to its average volume of 1,791,472. The firm has a market capitalization of $7.89 billion, a price-to-earnings ratio of 20.26, a PEG ratio of 2.26 and a beta of 0.81. The company has a current ratio of 1.38, a quick ratio of 0.75 and a debt-to-equity ratio of 0.50. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The stock's 50-day moving average is $71.41 and its 200-day moving average is $71.26.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The firm had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter in the prior year, the company posted $1.23 EPS. The company's quarterly revenue was up 3.3% on a year-over-year basis. As a group, research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Ratings Changes

Several equities analysts recently weighed in on HSIC shares. Stifel Nicolaus reaffirmed a "hold" rating and issued a $75.00 price target (down previously from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Barrington Research dropped their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 6th. Piper Sandler dropped their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. Evercore ISI raised their price target on shares of Henry Schein from $72.00 to $78.00 and gave the stock an "in-line" rating in a research note on Wednesday, July 9th. Finally, Wells Fargo & Company reduced their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Nine equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, Henry Schein has an average rating of "Hold" and a consensus price target of $78.08.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.